Key result
The COVID-19 pandemic period was associated with a significantly increased incidence of stress cardiomyopathy among patients with acute coronary syndrome compared to prepandemic periods (RR 4.58; P<.001).
Why the study?
It was not known whether the psychological, social, and economic stress of the COVID-19 pandemic was associated with an increase in the incidence of stress cardiomyopathy.
Does presentation during the COVID-19 pandemic increase the incidence of stress cardiomyopathy in patients presenting with acute coronary syndrome?
Population
1914 patients with acute coronary syndrome undergoing coronary arteriography across 2 hospitals
Comparison
COVID-19 pandemic period vs 4 prepandemic control timelines
Design
Retrospective cohort study
Authors
Loading...
Stress cardiomyopathy incidence rose during COVID-19; hypothesis-generating for pandemic stressors and requires prospective confirmation before clinical implications.
Cohort (n=1,914)
Yes
Does presentation during the COVID-19 pandemic increase the incidence of stress cardiomyopathy in patients presenting with acute coronary syndrome?
Relative Risk: 4.58 (95% CI 4.11–5.11)
p-value: p=<.001
The psychological, social, and economic stress of the COVID-19 pandemic was associated with a nearly 5-fold increase in the incidence of stress cardiomyopathy among patients presenting with acute coronary syndrome.
Jabri et al. (2020) conducted a cohort in Acute coronary syndrome (n=1,914). COVID-19 pandemic period vs. Prepandemic period was evaluated on Incidence of stress cardiomyopathy (Rate ratio 4.58, 95% CI 4.11-5.11, p=<.001). The COVID-19 pandemic period was associated with a significantly increased incidence of stress cardiomyopathy among patients with acute coronary syndrome compared to prepandemic periods (RR 4.58; P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: